Table 1. Misconceptions and facts about congenital cytomegalovirus.

cCMV: Congenital cytomegalovirus infection; IgG: Immunoglobulin G; TORCH: Toxoplasmosis, Other, Rubella, Cytomegalovirus, Herpes Simplex Virus; CMV:  cytomegalovirus

Data from [13]

Misconception	Fact
cCMV is uncommon.	It is the most prevalent TORCH infection at an incidence of 1 in every 200 live births.
cCMV is unpreventable.	Infection risk is lowered by frequent hand washing and avoiding small children’s saliva.
A woman is immune if she has a past history of CMV.	Even if a person has previously acquired IgG antibodies, they may reactivate a latent infection or contract a new strain of CMV while pregnant.
A neonate won't experience any aftereffects if they don't exhibit any cCMV symptoms at birth.	Babies who have cCMV but do not exhibit any symptoms at birth (referred to as asymptomatic cCMV) might still experience hearing impairment at birth and are susceptible to hearing impairment that develops later in life.
There is no treatment for neonates with asymptomatic cCMV.	Early intervention services and careful observation of vision, development and hearing can be a part of the treatment plan, as antiviral medications have not yet been marked risk-free in asymptomatic neonates.
Pediatricians diagnose the majority of newborns with cCMV at birth.	At birth, cCMV is misdiagnosed in over 90% of episodes. The majority of cCMV cases exhibit weak or nonexistent symptoms, making the diagnosis tricky.